Donna Snyder, MD, MBE
Executive Physician, WCG
Biography
Donna Snyder, MD, MBE, is the executive physician at WCG providing guidance on medicine, research, and regulations. Before WCG, Dr. Snyder served as senior pediatric ethicist, in the Office of Pediatric Therapeutics, at the Food and Drug Administration (FDA). She is a board-certified pediatrician with experience in pediatric practice and research ethics.
Latest insights by Donna
Review of the FDA Draft Guidance: Considerations for Including Tissue Biopsies in Clinical Trials
Blog Posts
Artificial Intelligence and Machine Learning in Clinical Trials
The Role of AI in Regulatory Decision-Making for Drugs & Biologics: the FDA’s Latest Guidance
Blog Posts
Ethics in Clinical Research
The FDA Accepts ICH E11A on Pediatric Extrapolation: How Does This Impact Your Pediatric Study?
Blog Posts
Regulatory Innovation
FDA’s Single IRB Requirement, Expected but Not Guaranteed in 2025
Blog Posts
Regulatory Compliance
Unpacking the FDA’s Guidance on Developing Drugs for Treatment in Pediatric Inflammatory Bowel Disease
Blog Posts
Ethics in Clinical Research
Demystifying FDA Processes: Why Do Changes in Regulations Take so Long?
Blog Posts
Ethics in Clinical Research
Ethical Review & AI in Clinical Trials
Podcasts
Ethics in Clinical Research
Revisiting the FDA’s Proposed Single IRB Mandate: Navigating Changes and Aligning for Success
Videos
Series: WCG Trends & Insights for 2024
The Impact of Artificial Intelligence (AI) on Ethical Review by IRBs
Blog Posts
Regulatory Compliance